BIOLINERX
Facebook
|
Twitter
|
Linkedin
| Careers | Contact Us
search

Investor relations home

BioLineRx is a publicly-traded (NASDAQ/TASE: BLRX), clinical-stage biopharmaceutical company based in Modi’in, Israel, dedicated to identifying, in-licensing and developing promising therapeutic candidates. The Company in-licenses novel compounds, primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/or co... More >>

Therapeutic pipeline
Title
Download Documentation Pipeline
Upcoming events
DateTitle
03/23/17 9:00 a.m. ET
BioLineRx Q4 2016 Earnings Conference Call
Download Event Supporting Material BioLineRx Reports Year End 2016 Financial Results
04/01/17
AACR
06/02/17
ASCO
What's new
DateTitle
02/09/17
Download Documentation BioLineRx Company presentation
Get help downloading or viewing the above file types


Interview with Philip Serlin, CEO
December 2016